The new “2022 India Ophthalmic Market Report” features updated forecasts through 2027 measuring the effect of the COVID-19 pandemic on the ophthalmic market and practices, with new analysis of corneal diseases and treatments, blindness, and visual impairment. The report examines newly available technologies, regulatory changes, the role of discount cards and private health insurance, and expansion plans from investor-owned clinics and ASC chains.
A corporate account gives you access to licensed reports and subscriptions, the latest news, a personalized dashboard, and weekly emails with news and data.